Journal of Comprehensive Pediatrics

Published by: Kowsar

Microbial Colonization and Drug Resistance in Patients with Cystic Fibrosis

Soheila Khalilzadeh 1 , Mohamad Boloursaz 1 , Nooshin Baghaie 1 , Elaheh Heydarian Fard 1 , Maryam Hassanzad 1 , * and Habib Emami 2
Authors Information
1 Pediatric Respiratory Disease Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Tobacco Prevention and Control Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Journal of Comprehensive Pediatrics: August 14, 2012, 3 (1); 25-28
  • Published Online: August 14, 2012
  • Article Type: Research Article
  • Received: September 20, 2011
  • Revised: September 30, 2011
  • Accepted: October 10, 2011
  • DOI: 10.17795/compreped-6944

To Cite: Khalilzadeh S, Boloursaz M, Baghaie N, Heydarian Fard E, Hassanzad M, et al. Microbial Colonization and Drug Resistance in Patients with Cystic Fibrosis, J Compr Ped. 2012 ;3(1):25-28. doi: 10.17795/compreped-6944.

Abstract
Copyright © 2012, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Richard E, Behrman RMK, Hal B. Jenson Text book of Pediatrics. Boat.Cystic Fibrosis. 2004;
  • 2. Kabra SK, Kabra M, Shastri S, Lodha R. Diagnosing and managing cystic fibrosis in the developing world. Paediatr Respir Rev. 2006;7(Suppl 1):S147-50.;
  • 3. Fares F, David M, Lerner A, Diukman R, Lerer I, Abeliovich D, et al. Paternal isodisomy of chromosome 7 with cystic fibrosis and overgrowth. Am J Med Genet A. 2006; 140(16): 1785-8[DOI][PubMed]
  • 4. Marks JH. Airway clearance devices in cystic fibrosis. Paediatr Respir Rev. 2007; 8(1): 17-23[DOI][PubMed]
  • 5. Fields TM, Michel SJ, Butler CL, Kriss VM, Albers SL. Abdominal manifestations of cystic fibrosis in older children and adults. AJR Am J Roentgenol. 2006; 187(5): 1199-203[DOI][PubMed]
  • 6. Green A, Kirk J. Guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis. Ann Clin Biochem. 2007; 44: 25-34[DOI][PubMed]
  • 7. Wall M. On staphylococcal prophylaxis in CF. Pediatr Pulmonol. 2007;42(2):186;; 42(2): 186[DOI][PubMed]
  • 8. Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther. 2006; 4(2): 261-75[DOI][PubMed]
  • 9. Kulczycki LL. Five decades of cystic fibrosis (1938-1988). Acta Univ Carol Med (Praha). 1990; 36(1-4): 7-12
  • 10. Therrell BL, Lloyd-Puryear MA, Mann MY. Understanding newborn screening system issues with emphasis on cystic fibrosis screening. J Pediatr. 2005; 147(3 Suppl)-10[DOI][PubMed]
  • 11. Katznelson D, Ben-Yishay M. Cystic fibrosis in Israel: clinical and genetic aspects. Isr J Med Sci. 1978; 14(2): 204-11[PubMed]
  • 12. Santana MA, Matos E, do Socorro Fontoura M, Franco R, Barreto D, Lemos AC. Prevalence of pathogens in cystic fibrosis patients in Bahia, Brazil. Braz J Infect Dis. 2003; 7(1): 69-72[DOI]
  • 13. Merqury N MJ. Clinical aspects of cystic fibrosis. Med Sci Monit. 2000; 11(12): 325-8
  • 14. Flume PA, Yankaskas JR, Ebeling M, Hulsey T, Clark LL. Massive hemoptysis in cystic fibrosis. Chest. 2005; 128(2): 729-38[DOI][PubMed]
  • 15. Santamaria F, Grillo G, Guidi G, Rotondo A, Raia V, de Ritis G, et al. Cystic fibrosis: when should high-resolution computed tomography of the chest Be obtained? Pediatrics. 1998; 101(5): 908-13[DOI][PubMed]
  • 16. McIlwaine M. Chest physical therapy, breathing techniques and exercise in children with CF. Paediatr Respir Rev. 2007; 8(1): 8-16[DOI][PubMed]
  • 17. Harrison F. Microbial ecology of the cystic fibrosis lung. Microbiology. 2007; 153: 917-23[DOI][PubMed]
  • 18. Ryan G, Mukhopadhyay S, Singh M. Nebulised anti-pseudomonal antibiotics for cystic fibrosis. Cochrane Database Syst Rev. 2003; (3)[PubMed]
  • 19. Ratjen F, Doring G, Nikolaizik WH. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Lancet. 2001; 358(9286): 983-4[DOI]
  • 20. Ebert DL, Olivier KN. Nontuberculous mycobacteria in the setting of cystic fibrosis. Clin Chest Med. 2002; 23(3): 655-63[DOI]
  • 21. Adeboyeku D, Scott S, Hodson ME. Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis. J Cyst Fibros. 2006; 5(4): 261-3[DOI][PubMed]
  • 22. Hart CA, Winstanley C. Persistent and aggressive bacteria in the lungs of cystic fibrosis children. Br Med Bull. 2002; 61: 81-96[DOI][PubMed]
  • 23. Eftekhar F RF, Khodadad A. Evaluation of Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Iran J of Infection and Tropical Medicine. 2003; 20(8): 14-7
  • 24. Kim DN, Lazarus AA. Management of bronchiectasis. Dis Mon. 2008; 54(8): 540-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments